Sientra to Present at the H.C. Wainwright Bioconnect Virtual Conference

Rhea-AI Summary

Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics firm based in Santa Barbara, California, announced management will present at the H.C. Wainwright Bioconnect Virtual Conference on January 10, 2022, at 7:00 AM ET. A pre-recorded presentation will be accessible via the company's investor relations website. Sientra focuses on innovative plastic surgery products, including the FDA-approved fifth-generation breast implants and Allox2® breast tissue expander, which features patented technology. The company aims to enhance patient care through advanced surgical solutions.

SANTA BARBARA, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that members of management will present at the upcoming H.C. Wainwright Bioconnect Virtual Conference.

A Pre-recorded presentation will be available on Monday, January 10th at 7:00 am Eastern Time. Interested parties may access a webcast of the presentation on the investor section of the Company’s website at www.Sientra.com.

About Sientra
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company exclusively focused on plastic surgery. The Company mission is to offer proprietary innovations and unparalleled partnerships that radically advance how plastic surgeons think, work and care for their patients. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company’s product portfolio includes its Sientra round and shaped breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2^® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM^®, the #1 performing, preferred and recommended scar gel of plastic surgeons(*).

Sientra uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Sientra is routinely posted and is accessible on the Company’s investor relations website at www.sientra.com.

^(*) Data on file

Investor Relations Contact
Leigh Salvo
ir@sientra.com

 

FAQ

When will Sientra present at the H.C. Wainwright Bioconnect Virtual Conference?

Sientra will present on January 10, 2022, at 7:00 AM ET.

How can I access Sientra's presentation from the conference?

The presentation will be available on Sientra's investor relations website.

What products does Sientra offer?

Sientra offers FDA-approved fifth-generation breast implants, Allox2® breast tissue expander, and BIOCORNEUM® scar gel.

What is the focus of Sientra as a company?

Sientra is focused on medical aesthetics and advancing plastic surgery through proprietary innovations.

Where is Sientra located?

Sientra is headquartered in Santa Barbara, California.